Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results

January 7, 2024

https://www.prnewswire.com/news-releases/accelerate-diagnostics-announces-certain-preliminary-fourth-quarter-and-full-year-2023-results-302027792.html

TUCSON, Ariz., Jan. 7, 2024 /PRNewswire/ —  Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections, today announced certain preliminary, unaudited results for the quarter and year ended December 31, 2023.

Read more at prnewswire.com

Related news for (AXDX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.